Fabrinet rises as investors lean on strong earnings, upbeat outlook

Fabrinet (FN) is up 5.0% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely driver is continued investor support for Fabrinet’s strong fiscal fourth-quarter results and upbeat near-term outlook released in August 2026. If there was no fresh company-specific announcement today, the gain could also reflect a rebound in sentiment around AI and optical-networking suppliers after a recent pullback.

Details:

Fabrinet posted record fourth-quarter fiscal 2026 revenue of about $1.316 billion, up sharply from the prior year and above its own guidance range.

Quarterly profitability also improved meaningfully, with GAAP diluted earnings per share of $3.83 and non-GAAP diluted earnings per share of $4.10.

Management guided for fiscal first-quarter revenue of $1.375 billion to $1.425 billion and non-GAAP diluted earnings per share of $4.10 to $4.25, signaling that demand trends remained solid heading into the new fiscal year.

Fabrinet also ended fiscal 2026 with roughly $169 million still available under its share repurchase authorization, which can support sentiment even when it is not the main catalyst.

Sources:

Fabrinet Investor Relations, SEC, Benzinga

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

EARLY ACCESS

Receive FN Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$FN Hedge Fund Activity

We have seen 432 institutional investors add shares of $FN stock to their portfolio, and 353 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

PRICE T ROWE ASSOCIATES INC /MD/ removed 1,901,863 shares (-49.5%) from their portfolio in Q2 2026, for an estimated $1,068,999,155
JPMORGAN CHASE & CO added 1,575,418 shares (+inf%) to their portfolio in Q2 2026, for an estimated $885,510,949
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 848,320 shares (+112808.5%) to their portfolio in Q2 2026, for an estimated $476,823,705
BLACKROCK, INC. removed 774,150 shares (-13.8%) from their portfolio in Q2 2026, for an estimated $435,134,232
ALLIANCEBERNSTEIN L.P. removed 525,169 shares (-92.3%) from their portfolio in Q2 2026, for an estimated $295,186,991
WASATCH ADVISORS LP removed 460,251 shares (-65.5%) from their portfolio in Q2 2026, for an estimated $258,697,882
JANE STREET GROUP, LLC added 428,582 shares (+1011.2%) to their portfolio in Q2 2026, for an estimated $240,897,370

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$FN Congressional Stock Trading

Members of Congress have traded $FN stock 5 times in the past 6 months. Of those trades, 3 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $FN stock by members of Congress over the last 6 months:

REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 2 purchases worth up to $65,000 on 05/04, 03/27 and 1 sale worth up to $50,000 on 07/16.
REPRESENTATIVE JOSH GOTTHEIMER has traded it 2 times. They made 1 purchase worth up to $15,000 on 05/01 and 1 sale worth up to $15,000 on 07/14.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$FN Price Targets

Multiple analysts have issued price targets for $FN recently. We have seen 4 analysts offer price targets for $FN in the last 6 months, with a median target of $726.0.

Here are some recent targets:

Tim Long from Barclays set a target price of $702.0 on 05/06/2026
Ryan Koontz from Needham set a target price of $800.0 on 05/05/2026
Mike Genovese from Rosenblatt set a target price of $750.0 on 05/05/2026
Samik Chatterjee from JP Morgan set a target price of $680.0 on 05/05/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.